Loading...
XSTODOXA
Market cap64mUSD
Dec 23, Last price  
0.56SEK
1D
-1.58%
1Q
-49.00%
Jan 2017
-78.43%
IPO
-83.91%
Name

Doxa AB

Chart & Performance

D1W1MN
XSTO:DOXA chart
P/E
2.47
P/S
72.85
EPS
0.23
Div Yield, %
0.00%
Shrs. gr., 5y
34.80%
Rev. gr., 5y
-21.76%
Revenues
10m
+90.38%
1,823,0005,00049,000863,0001,005,0002,193,0006,159,0008,998,00015,013,00017,544,00016,330,00033,758,00019,274,0008,541,00010,900,0005,200,0009,900,000
Net income
292m
P
-38,943,000-50,288,000-33,597,000-16,455,000-62,886,000-37,379,000-19,490,000-18,488,000-15,932,000-10,743,000-10,560,0008,018,000-11,273,000-13,692,00076,200,000-33,000,000291,900,000
CFO
-38m
L-1.82%
-37,140,000-22,875,000-6,453,000-30,247,000-50,419,000-29,896,000-20,248,000-18,201,000-17,344,000-9,705,000-8,212,00010,742,000-9,174,000-14,282,000-18,600,000-38,500,000-37,800,000

Profile

Doxa AB (publ), a dental company, develops, manufactures, and commercializes bioceramic dental products under the Ceramir brand worldwide. It offers Crown & Bridge, a dental cement that is used for permanent cementing of crowns and bridges. The company was founded in 1987 and is based in Uppsala, Sweden.
URL
https://www.doxa.se/
IPO date
Apr 07, 2014
Employees
7
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
9,900
90.38%
5,200
-52.29%
10,900
27.62%
Cost of revenue
40,800
35,000
Unusual Expense (Income)
NOPBT
9,900
(35,600)
(24,100)
NOPBT Margin
100.00%
Operating Taxes
(6,900)
100
Tax Rate
NOPAT
9,900
(28,700)
(24,200)
Net income
291,900
-984.55%
(33,000)
-143.31%
76,200
-656.53%
Dividends
Dividend yield
Proceeds from repurchase of equity
244,700
350,500
422,800
BB yield
-18.52%
-25.66%
-28.37%
Debt
Debt current
6,100
1,400
Long-term debt
14,200
10,200
Deferred revenue
Other long-term liabilities
200,200
6,700
1,500
Net debt
(2,614,900)
(1,756,400)
(874,700)
Cash flow
Cash from operating activities
(37,800)
(38,500)
(18,600)
CAPEX
(900)
Cash from investing activities
(205,100)
(267,300)
(392,900)
Cash from financing activities
294,700
350,700
422,100
FCF
(29,900)
(41,600)
(22,846)
Balance
Cash
111,900
60,000
15,100
Long term investments
2,523,300
1,708,000
859,600
Excess cash
2,634,705
1,767,740
874,155
Stockholders' equity
364,600
(42,600)
(57,800)
Invested Capital
3,073,600
1,823,500
929,100
ROIC
0.40%
ROCE
0.29%
EV
Common stock shares outstanding
387,531
281,048
113,763
Price
3.41
-29.84%
4.86
-62.90%
13.10
878.04%
Market cap
1,321,482
-3.25%
1,365,894
-8.35%
1,490,291
1,168.88%
EV
(1,293,418)
(200,406)
615,591
EBITDA
11,900
(35,500)
(23,400)
EV/EBITDA
5.65
Interest
2,100
1,000
100
Interest/NOPBT
21.21%